Disease/Infection News

RSS

Research identifies a unique protein fingerprint linked to very short sleep and increased diabetes risk

Study highlights the association between sleep duration and proteomic fingerprints, finding that very short sleep is linked to proteins involved in inflammation and cell death that increase the risk of diabetes mellitus (DM) but not coronary heart disease (CHD).

1 May 2024

Avian flu crosses species, infecting cats and cattle in Texas and Kansas

A study in the CDC's Emerging Infectious Disease Journal reports the spread of H5N1 avian influenza among cats and dairy cattle in Texas and Kansas, showing systemic illness in cattle and significant fatalities in cats exposed to the virus through infected milk.

1 May 2024

New monoclonal antibody vaccine slashes malaria risk in children

A recent study demonstrates that the monoclonal antibody-based vaccine L9LS is safe for children aged 6 to 10 and significantly reduces the risk of malaria infection and clinical symptoms by 70% and 77%, respectively.

30 Apr 2024

Gut bacteria and urinary infections linked, offering new angles for treatment

A study in eClinicalMedicine explores the relationship between gut microbiota, urinary tract colonization, and recurrent urinary tract infections (rUTI), suggesting the cross-habitation of uropathogenic E. coli as a significant mechanism in rUTI recurrence.

30 Apr 2024

Study shows continued willingness to get vaccinated across 23 countries

A substantial proportion of the world's population remains willing to get vaccinated against diseases including COVID-19, according to a new survey across 23 countries that represent more than 60% of the world's population.

30 Apr 2024

Updated vaccine provides strong immune response against previous and emerging SARS-CoV-2 variants

New research using live SARS-CoV-2 virus reveals an updated vaccine provides a strong immune response against previous strains and emerging variants.

29 Apr 2024

New SARS-CoV-2 KP.2 variant defies vaccines with higher spread, study warns

Study on the bioRxiv server reports that the SARS-CoV-2 KP.2 variant, despite lower infectivity, shows significant immune resistance and higher transmissibility compared to other variants, potentially impacting global public health and vaccine efficacy.

29 Apr 2024

Hospital toilets harbor multi-drug resistant "superbugs", study finds

Pathogenic bacteria and fungi, including multi-drug resistant "superbugs" have been found on the floors, ceilings, door handles and other surfaces of hospital toilets in the UK, with patient toilets the worst affected, the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) will hear.

29 Apr 2024

Age and sex impact antimicrobial resistance levels, research shows

New research presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona 27-30 April) shows that levels of resistance to antimicrobials (AMR) varies with age and sex, with age in particular showing substantial variation both between and within countries.

29 Apr 2024

Study reveals genetic divergence and drug resistance mechanisms in two critical superbugs

Infectious diseases caused by pathogenic strains of bacteria are a global cause of morbidity and mortality. Hospital-acquired infections caused by Klebsiella pneumonia and Pseudomonas aeruginosa were found vulnerable during the COVID-19 pandemic.

29 Apr 2024

Do SARS-CoV-2 infections cause long-term loss of smell and taste?

The long-term smell and taste-associated outcomes of coronavirus disease 2019 (COVID-19) using validated psychophysical tests.

29 Apr 2024

Expert warns of the continuous dangers posed by polio and other enteroviruses

Consistently high vaccination rates and global health surveillance programs have helped eliminate poliomyelitis (polio) in almost all countries of the world, except Afghanistan and Pakistan.

28 Apr 2024

New study reveals global risk distribution of visceral leishmaniasis

Announcing a new article publication for Zoonoses journal. Visceral leishmaniasis (VL) is a vector-borne disease posing increasing public health concerns.

28 Apr 2024

New study reveals potential cellular mechanism behind cognitive decline in Alzheimer's

Researchers have developed a robust method for identifying rare brain neurons that re-enter the cell cycle, offering insights into their role in cognitive disorders such as Alzheimer's disease.

28 Apr 2024

Dr. James Gill's insights on combating the global crisis of antimicrobial resistance

Dr. James Gill, a Clinical Lecturer at the University of Warwick and a practicing GP, will attend a pivotal event hosted at the House of Lords on Monday (April 29) focused on combating the global crisis of antimicrobial resistance (AMR).

27 Apr 2024

Harnessing immune enhancement to combat drug-resistant tuberculosis

Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease.

26 Apr 2024

Leveraging CRISPR/Cas technology to address antimicrobial resistance

In the second new research review on this subject, Assistant Prof. Ibrahim Bitar, Department of Microbiology, Faculty of Medicine and University Hospital in Plzen, Charles University in Prague, Plzen, Czech Republic, will give an overview of the molecular biology of CRISPR technology in explaining how it can used to tackle antimicrobial resistance.

26 Apr 2024

Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows

One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country's six-month malaria season, according to the results of a mid-stage clinical trial.

26 Apr 2024

Novel SYBR green-based RT-qPCRs developed for lone star virus detection

Announcing a new article publication for Zoonoses journal. Lone Star virus (LSV) is a newly characterized arbovirus with pathogenic potential.

26 Apr 2024

Revvity unveils a new era of automated tuberculosis testing

Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is easy to use and designed to provide efficient workflows in the lab. When the accuracy of the T-SPOT.TB test is combined with the efficiency of the Auto-Pure 2400 system, labs, clinicians and ultimately patients, benefit from the resultant powerful solution.

From Revvity 26 Apr 2024